Can a bladder shield make cancer treatment more tolerable?

NCT ID NCT07495072

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 56 adults with non-muscle-invasive bladder cancer who receive BCG therapy, a standard treatment that often causes painful bladder symptoms. Researchers want to see if giving Blad-Care (a gel that restores the bladder's protective lining) early during BCG treatment works better than waiting until after BCG is done. The goal is to reduce irritation like pain and urgency, helping patients complete their cancer therapy with less discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BCG-INDUCED CYSTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial cystitis non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms urinary bladder neoplasm Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kyung Hee University Hospital

    RECRUITING

    Seoul, Dongdaemun-gu, 02447, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.